QMed, Inc. engages in developing evidence-based clinical information management systems. The company is headquartered in Eatontown, New Jersey and currently employs 28 full-time employees. The services of QMed include Online Health Management System for Cardiovascular Disease (ohms/cvd), which is an integrated cardiovascular disease management system. ohms/cvd includes related systems to assist health plans and government organizations in managing the care, and cost of diabetes, cardiovascular conditions, including coronary artery disease (CAD), stroke, heart failure (CHF), hypertension, hyperlipidemia and the cardiovascular complications of diabetes. On November 2007, the Company ceased operations of its Managed Care Special Needs Plans and related services. On October 2007, it also sold its medical equipment business to an unaffiliated third party.
QMED stock price ended at $0 on 月曜日, after dropping NaN%
On the latest trading day Mar 24, 2025, the stock price of QMED fell by NaN%, dropping from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. On the latest trading day, the trading volume for QMED decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 165 shares were traded, with a market value of approximately --.